JCI - Citations to Biallelic inactivation of REV7 is associated with Fanconi anemia

Published March 1, 2017
Citation Information: J Clin Invest. 2017;127(3):1117-1117. https://doi.org/10.1172/JCI92946.

Year:	2022	2021	2020	2019	2018	Total
Citations:	2	1	1	1	2	7

Citation information

Title and authors	Publication	Year
Disrupting the MAD2L2-Rev1 Complex Enhances Cell Death upon DNA Damage N Pernicone, M Elias, I Onn, D Tobi, T Listovsky	Molecules (Basel, Switzerland)	2022
Inherited bone marrow failure in the pediatric patient Dokal I, Tummala H, Vulliamy T	Blood	2022
The Protexin complex counters resection on stalled forks to promote homologous recombination and crosslink repair RO Adeyemi, NA Willis, AE Elia, C Clairmont, S Li, X Wu, AD DAndrea, R Scully, SJ Elledge	Molecular Cell	2021
The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links X Renaudin, F Rosselli	Genes & development	2020
DNA damage tolerance in stem cells, ageing, mutagenesis, disease and cancer therapy B Pilzecker, OA Buoninfante, H Jacobs	Nucleic Acids Research	2019
Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Cancer Surveillance in Fanconi Anemia SA Savage, MF Walsh	Hematology/Oncology Clinics of North America	2018
Icariin improves Fanconi anemia hematopoietic stem cell function through SIRT6-mediated NF-kappa B inhibition Y Li, X Li, A Cole, S McLaughlin, W Du	Cell cycle (Georgetown, Tex.)	2018